Trastuzumab

A*STAR scientists aim to design better immunotherapies by simulating the binding of antibodies to their targets.

By taking advantage of the body’s
natural diversity, antibody drugs can be made less toxic by having a more localized
effect

The
light chain subunits of therapeutic antibodies impact drug performance and yield